Selected Publications

Pohlmann P R, Abdou Y, Johnson M, Maziarz RT, Specht J, Dees E Claire, Yuan Y, Tanyi J, Angelos M, Gill S, Wetzel J, Cushing D, Klichinsky M, Condamine T, and Reiss K: A Phase 1, First in Human (FIH) study of autologous macrophages engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants (pts) with HER2 overexpressing solid tumors. ASCO Chicago, IL (TIP- Trail in progress) : 2024.

Simpkins F, Nasioudis D, Wethington S, Martin L. Tanyi, J, Latif N, Torigian D, Omran D, Rodriguez D, Smith S, Dean E, Domchek S, Drapkin R, Shih I, Brown, E, Hwang W, Armstrong D, Gaillard S, Giuntoli R, Liu J: Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-sensitive epithelial ovarian cancer (cohort A). ASCO, 2024, Annual Meeting. Chicago, IL : 2024.

Wagner P, Levine EA, Kim AC, Shen P, Fleming ND, Westin SN, Berry LK, Karakousis GC, Tanyi JL, Olson MT, Madajewski B, Ostrander B, Krishnan K, Balch CM, Bartlett DL.: ASO Visual Abstract: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent-Final Results from a Phase 2 Study Ann Surg Oncol. : doi: 10.1245/s10434-024-15307-8. Online ahead of print,2024.

Cutri-French C, Nasioudis D, George E, Tanyi JL.: CAR-T Cell Therapy in Ovarian Cancer: Where Are We Now? Diagnostics (Basel) : 14(8):819,2024.

Li S, Tanyi J, Cory L, Mangalmurti NS: Detection of HPV DNA on Red Blood Cells. Oral presentation. OncLive Gynecologic Oncology Fellows Forum. Austin, TX. : 2024.

Talekar Mala K, Brozena Loretta J, Lazar Besmira, Xu Jun, Luke Raymond A, Howard Susan, Stief Jacqueline, Sterman Daniel H, O'Hara Mark H, Haas Andrew R, Altan Mehmet, Tanyi Janos L, Johnson Laura A: STAR-101: A Phase 1 FIH Clinical Trial of SynKIRTM-110 in Patients with Cholangiocarcinoma, Mesothelioma, or Ovarian Cancer Cholangiocarcinoma Foundation Annual Conference in Salt Lake City, Utah : 2024.

Wagner P, Levine EA, Kim AC, Shen P, Fleming ND, Westin SN, Berry LK, Karakousis GC, Tanyi JL, Olson MT, Madajewski B, Ostrander B, Krishnan K, Balch CM, Bartlett DL.: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II Study Ann Surg Oncol : doi: 10.1245/s10434-024-15165-4. Online ahead of print,2024.

Tanyi Janos L, Haas Andrew R, Aggarwal Charu, O'Hara Mark, Fraietta Joseph A, Golden Ryan, Hwang Wei-Ting, Young Regina M, Shea Kim, Dowd Emily, Marshall Amy, Barber-Rotenberg Julie S, Jadlowsky Julie K, Chew Anne, Sheppard Neil C, Albelda Steven, June Carl H: Phase I clinical trial of autologous T cells bearing fully-humanized chimeric antigen receptors (CAR-T) targeting mesothelin with both intravenous administration and local delivery with or without lymphodepletion in mesothelin-expressing cancers including ovarian cancer. SGO Annual Meeting. San Diego, California : 2024.

Tanyi Janos L, O'Hara Mark, Hexner Elizabeth, Marshall Amy, Jadlowsky Julie K, Ferrara Matthew, Farrelly Olivia, Runkle Adam, Chew Anne, Dowd Emily, Gonzalez Vanessa, Fraietta Joseph A, Plesa Gabriela, Sheppard Neil C, June Carl H: Phase 1 Trial of Human Chimeric Antigen Receptor Modified T Cells (huCART-meso) Administered in Combination with Oncolytic Virus VCN-01 in Patients with Pancreatic and Ovarian Cancer. Society of Immunotherapy of Cancer, 38th Annual Meeting, San Diego, California. : 2023.

Bobisse S, Bianchi V, Tanyi JL, Sarivalasis A, Missiaglia E, Pétremand R, Benedetti F, Torigian DA, Genolet R, Barras D, Michel A, Mastroyannis SA, Zsiros E, Dangaj Laniti D, Tsourti Z, Stevenson BJ, Iseli C, Levine BL, Speiser DE, Gfeller D, Bassani-Sternberg M, Powell DJ Jr, June CH, Dafni U, Kandalaft LE, Harari A, Coukos G: A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer Nat. Cancer : 4(10):1410-1417,2023.

Academic Contact Information

Department of Obstetrics and Gynecology
Jordan Center for Gynecologic Cancer at Penn
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard, 3 West
Philadelphia, PA 19104
Phone: 215-662-3318
Patient appointments: 800-789-7366